SRC and malignant colon neoplasm: Furthermore, inhibition of Src using the ATP binding competitive inhibitor dasatinib decreased the development of liver metastases in a murine model of pancreatic carcinoma and caused a decrease in cell adhesion, migration and invasion in colon cancer cell lines.